262 results
Page 5 of 14
PRE 14A
k2jepf8t7p9krt
11 Mar 19
Preliminary proxy
5:07pm
8-K
EX-99.1
2tpaebm3k cg
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
pvs7ytoj6hgwva
15 Jan 19
Entry into a Material Definitive Agreement
5:19pm
424B5
0g2 rkixn8
15 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
14pa2rwai53e
14 Jan 19
Prospectus supplement for primary offering
4:41pm
8-K
EX-99.1
syaxe1p55
7 Jan 19
Results of Operations and Financial Condition
8:11am
8-K
EX-99.1
0kd7uvjxkgyo4
7 Nov 18
Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity
8:16am
8-K
EX-99.1
5myr86aq
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
8-K
EX-99.1
dx6le42
2 Aug 18
Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity
8:15am
8-K
EX-99.1
x4tqp fz9
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
c3zntp 3q
20 Apr 18
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
12:00am